Prognostic Relevance of Cytochrome c Oxidase in Primary Glioblastoma Multiforme

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Griguer, Corinne E ^a   Cantor, Alan B ^c   Fathallah Shaykh, Hassan M ^b   Gillespie, G Yancey ^a   Gordon, Amber S ^a   Markert, James M ^a   Radovanovic, Ivan ^d   Clement Schatlo, Virginie ^d   Shannon, Chevis N ^a   Oliva, Claudia R ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE;

ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; OXIDATION KINETICS; PRIMARY TUMOR; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SPECTROPHOTOMETRY; SURVIVAL TIME;

BASE SEQUENCE; BRAIN NEOPLASMS; DNA METHYLATION; DNA PRIMERS; ELECTRON TRANSPORT COMPLEX IV; GLIOBLASTOMA; HUMANS; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84876047533     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061035     Document Type: Article

References (23)

1. Hegi ME, Liu L, Herman JG, Stupp R, Wick W, et al. (2008) Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 26: 4189-4199.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
3. Huttemann M, Muhlenbein N, Schmidt TR, Grossman LI, Kadenbach B, (2000) Isolation and sequence of the human cytochrome c oxidase subunit VIIaL gene. Biochim Biophys Acta 1492: 252-258.
4. Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, et al. (2011) Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol 29: 4482-4490.
5. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, et al. (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360: 765-773.
6. Oliva CR, Moellering DR, Gillespie GY, Griguer CE, (2011) Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production. PLoS One 6: e24665.
7. Oliva CR, Nozell SE, Diers A, McClugage SG, Sarkaria JN, et al. (2010) Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain. J Biol Chem 285: 39759-39767.
8. Grossman LI, Lomax MI, (1997) Nuclear genes for cytochrome c oxidase. Biochim Biophys Acta 1352: 174-192.
9. Kadenbach B, Huttemann M, Arnold S, Lee I, Bender E, (2000) Mitochondrial energy metabolism is regulated via nuclear-coded subunits of cytochrome c oxidase. Free Radic Biol Med 29: 211-221.
10. Campian JL, Gao X, Qian M, Eaton JW, (2007) Cytochrome C oxidase activity and oxygen tolerance. J Biol Chem 282: 12430-12438.
11. Seelan RS, Grossman LI, (1997) Structural organization and promoter analysis of the bovine cytochrome c oxidase subunit VIIc gene. A functional role for YY1. J Biol Chem 272: 10175-10181.
12. Landriscina M, Maddalena F, Laudiero G, Esposito F, (2009) Adaptation to oxidative stress, chemoresistance, and cell survival. Antioxid Redox Signal 11: 2701-2716.
13. Santandreu FM, Brell M, Gene AH, Guevara R, Oliver J, et al. (2008) Differences in mitochondrial function and antioxidant systems between regions of human glioma. Cell Physiol Biochem 22: 757-768.
14. Schmidt TR, Jaradat SA, Goodman M, Lomax MI, Grossman LI, (1997) Molecular evolution of cytochrome c oxidase: rate variation among subunit VIa isoforms. Mol Biol Evol 14: 595-601.
15. Wu W, Goodman M, Lomax MI, Grossman LI, (1997) Molecular evolution of cytochrome c oxidase subunit IV: evidence for positive selection in simian primates. J Mol Evol 44: 477-491.
16. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG, (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59: 793-797.
17. Shi J, Zhang G, Yao D, Liu W, Wang N, et al. (2012) Prognostic significance of aberrant gene methylation in gastric cancer. Am J Cancer Res 2: 116-129.
18. Fern R, (2003) Variations in spare electron transport chain capacity: The answer to an old riddle? J Neurosci Res 71: 759-762.
19. Liu X, Kim CN, Yang J, Jemmerson R, Wang X, (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157.
20. Bossy-Wetzel E, Newmeyer DD, Green DR, (1998) Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 17: 37-49.
21. Jones DP, Orrenius S, Mason HS, (1979) Hemoprotein quantitation in isolated hepatocytes. Biochim Biophys Acta 576: 17-29.
22. Kennedy FG, Jones DP, (1986) Oxygen dependence of mitochondrial function in isolated rat cardiac myocytes. Am J Physiol 250: C374-383.
23. Villani G, Greco M, Papa S, Attardi G, (1998) Low reserve of cytochrome c oxidase capacity in vivo in the respiratory chain of a variety of human cell types. J Biol Chem 273: 31829-31836.